Wal-Mart expands $4 generic program NFID and CDC to spend $5 million on flu information Dey and Critical Theraputics launch Zyflo in U.S. Supreme Court to decide on Warner-Lambert case FDA alerts consumers over concerns regarding Cephalon's Fentora FDA approves Watson's generic AccuNeb MinuteClinic announces openings in Pennsylvania cities FDA requests Alcon run more tests on Retaane Exclusive Drug Store News interview: Anderson hopeful for delay A new clinical data recently showed that patients with uncontrolled Type 2 diabetes treated with metformin were four times more likely to achieve recommended blood sugar control levels by adding Galvus to their treatment compared to those who took a place First Previous 1804 1805 1806 1807 1808 Next Last
